News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
246,247 Results
Type
Article (5859)
Company Profile (20)
Press Release (240368)
Section
Business (87739)
Career Advice (470)
Deals (16487)
Drug Delivery (9)
Drug Development (21379)
Employer Resources (32)
FDA (4051)
Job Trends (4558)
News (129941)
Policy (8426)
Tag
Academia (338)
Accelerated approval (2)
Adcomms (3)
Allergies (9)
Alliances (16215)
ALS (24)
Alzheimer's disease (319)
Antibody-drug conjugate (ADC) (17)
Approvals (4074)
Artificial intelligence (51)
Autoimmune disease (5)
Automation (4)
Bankruptcy (107)
Best Places to Work (3395)
Biosimilars (12)
Biotechnology (28)
Bladder cancer (14)
Brain cancer (8)
Breast cancer (71)
Cancer (539)
Cardiovascular disease (29)
Career advice (402)
Career pathing (3)
CAR-T (37)
Cell therapy (116)
Cervical cancer (2)
Clinical research (17916)
Collaboration (205)
Compensation (187)
Complete response letters (3)
COVID-19 (453)
CRISPR (8)
C-suite (118)
Cystic fibrosis (17)
Data (627)
Depression (9)
Diabetes (49)
Diagnostics (2263)
Digital health (4)
Diversity, equity & inclusion (13)
Drug discovery (27)
Drug pricing (7)
Drug shortages (1)
Duchenne muscular dystrophy (15)
Earnings (43307)
Editorial (2)
Employer branding (6)
Employer resources (33)
Events (40746)
Executive appointments (349)
FDA (4413)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (3)
Funding (238)
Gene editing (17)
Generative AI (2)
Gene therapy (54)
GLP-1 (131)
Government (508)
Guidances (92)
Healthcare (5575)
Huntington's disease (1)
IgA nephropathy (4)
Immunology and inflammation (16)
Indications (6)
Infectious disease (472)
Inflammatory bowel disease (24)
Inflation Reduction Act (2)
Influenza (3)
Intellectual property (15)
Interviews (57)
IPO (8426)
IRA (3)
Job creations (1260)
Job search strategy (365)
Kidney cancer (7)
Labor market (5)
Layoffs (107)
Leadership (5)
Legal (2678)
Liver cancer (18)
Lung cancer (60)
Lymphoma (36)
Management (11)
Manufacturing (62)
MASH (30)
Medical device (4309)
Medtech (4311)
Mergers & acquisitions (8319)
Metabolic disorders (138)
Multiple sclerosis (13)
NASH (6)
Neurodegenerative disease (14)
Neuropsychiatric disorders (2)
Neuroscience (447)
NextGen: Class of 2025 (1803)
Non-profit (794)
Now hiring (3)
Obesity (59)
Opinion (32)
Ovarian cancer (18)
Pain (17)
Pancreatic cancer (20)
Parkinson's disease (31)
Partnered (8)
Patents (31)
Patient recruitment (34)
Peanut (5)
People (26503)
Pharmaceutical (8)
Pharmacy benefit managers (2)
Phase I (5326)
Phase II (7914)
Phase III (6168)
Pipeline (749)
Policy (9)
Postmarket research (658)
Preclinical (2105)
Press Release (67)
Prostate cancer (29)
Psychedelics (5)
Radiopharmaceuticals (120)
Rare diseases (81)
Real estate (2016)
Recruiting (9)
Regulatory (5677)
Reports (16)
Research institute (350)
Resumes & cover letters (68)
Rett syndrome (5)
RNA editing (1)
Schizophrenia (28)
Series A (33)
Series B (25)
Service/supplier (2)
Sickle cell disease (8)
Special edition (1)
Spinal muscular atrophy (30)
Sponsored (5)
Startups (1125)
State (1)
Stomach cancer (1)
Supply chain (12)
Tariffs (5)
Vaccines (61)
Venture capitalists (3)
Weight loss (23)
Women's health (1)
Date
Today (105)
Last 7 days (409)
Last 30 days (1213)
Last 365 days (10914)
2025 (4270)
2024 (12240)
2023 (14545)
2022 (20462)
2021 (21874)
2020 (19720)
2019 (14303)
2018 (11020)
2017 (10880)
2016 (10002)
2015 (13157)
2014 (10373)
2013 (8360)
2012 (9047)
2011 (9450)
2010 (9268)
Location
Africa (199)
Alabama (15)
Alaska (2)
Arizona (68)
Arkansas (1)
Asia (12195)
Australia (1678)
California (2233)
Canada (1150)
China (83)
Colorado (95)
Connecticut (105)
Delaware (38)
Europe (26028)
Florida (328)
Georgia (40)
Idaho (23)
Illinois (122)
India (7)
Indiana (86)
Iowa (2)
Japan (85)
Kansas (25)
Kentucky (12)
Louisiana (5)
Maine (42)
Maryland (245)
Massachusetts (1790)
Michigan (110)
Minnesota (155)
Mississippi (1)
Missouri (23)
Montana (16)
Nebraska (14)
Nevada (30)
New Hampshire (24)
New Jersey (770)
New Mexico (8)
New York (569)
North Carolina (374)
North Dakota (3)
Northern California (1069)
Ohio (64)
Oklahoma (7)
Oregon (4)
Pennsylvania (422)
Puerto Rico (2)
Rhode Island (13)
South America (307)
South Carolina (9)
Southern California (804)
Tennessee (49)
Texas (303)
United States (8349)
Utah (69)
Virginia (50)
Washington D.C. (11)
Washington State (193)
West Virginia (2)
Wisconsin (37)
246,247 Results for "gtx corp".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Halberd Corp. Signs Significant Revenue Sharing Agreement with Athena GTX
Halberd Corporation is thrilled to declare the formalization of a profitable revenue-sharing accord with Athena GTX, Inc., of Johnston, Iowa,. Athena GTX is a private enterprise specializing in providing medical care solutions tailored for first responders in both civilian and government sectors.
January 9, 2024
·
5 min read
Press Releases
Grace Therapeutics Announces Alignment with the FDA Supporting the Planned NDA Submission for GTx-104
April 9, 2025
·
8 min read
Press Releases
Sharp Therapeutics Corp. Nominates Clinical Candidate for Gaucher’s Disease
May 13, 2025
·
4 min read
Press Releases
BioSig Enters into an LOI to Merge with Streamex Exchange Corp.
May 6, 2025
·
4 min read
Press Releases
AdaptHealth Corp. Announces First Quarter 2025 Results
May 6, 2025
·
17 min read
Press Releases
Grace Therapeutics Announces Results From Pivotal Phase 3 STRIVE-ON Safety Trial of GTx-104 in aSAH
February 10, 2025
·
10 min read
Press Releases
OrthoPediatrics Corp. Continued Leading Sponsorship at 2025 POSNA Annual Meeting
May 15, 2025
·
1 min read
Press Releases
180 Life Sciences Corp. Announces Share Repurchase
April 30, 2025
·
7 min read
Drug Development
Ultragenyx Announces Positive Interim Phase 1/2 Data in Patients with Angelman Syndrome After Treatment with GTX-102
Ultragenyx Pharmaceutical Inc. announced new data from the Phase 1/2 study of GTX-102 for the treatment of Angelman syndrome.
April 15, 2024
·
12 min read
Press Releases
OrthoPediatrics Corp. Expands Scoliosis Portfolio with Launch of VerteGlide™ System
April 9, 2025
·
2 min read
1 of 24,625
Next
